Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 3
2006 1
2007 1
2008 1
2009 4
2010 3
2011 1
2012 2
2013 4
2014 2
2015 4
2016 2
2017 3
2019 3
2020 1
2021 8
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus.
Taha Z, Crupi MJF, Alluqmani N, Fareez F, Ng K, Sobh J, Lee E, Chen A, Thomson M, Spinelli MM, Ilkow CS, Bell JC, Arulanandam R, Diallo JS. Taha Z, et al. Among authors: arulanandam r. Front Immunol. 2023 Apr 19;14:1181014. doi: 10.3389/fimmu.2023.1181014. eCollection 2023. Front Immunol. 2023. PMID: 37153626 Free PMC article.
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy.
Wong B, Bergeron A, Maznyi G, Ng K, Jirovec A, Birdi HK, Serrano D, Spinelli M, Thomson M, Taha Z, Alwithenani A, Chen A, Lorimer I, Vanderhyden B, Arulanandam R, Diallo JS. Wong B, et al. Among authors: arulanandam r. Mol Ther. 2023 Nov 1;31(11):3176-3192. doi: 10.1016/j.ymthe.2023.09.017. Epub 2023 Sep 27. Mol Ther. 2023. PMID: 37766429
Engaged for survival: From cadherin ligation to STAT3 activation.
Geletu M, Guy S, Arulanandam R, Feracci H, Raptis L. Geletu M, et al. Among authors: arulanandam r. JAKSTAT. 2013 Oct 1;2(4):e27363. doi: 10.4161/jkst.27363. Epub 2013 Dec 6. JAKSTAT. 2013. PMID: 24470979 Free PMC article. Review.
The R(h)oads to Stat3: Stat3 activation by the Rho GTPases.
Raptis L, Arulanandam R, Geletu M, Turkson J. Raptis L, et al. Among authors: arulanandam r. Exp Cell Res. 2011 Aug 1;317(13):1787-95. doi: 10.1016/j.yexcr.2011.05.008. Epub 2011 May 18. Exp Cell Res. 2011. PMID: 21619876 Free PMC article. Review.
Enhancement of oncolytic virotherapy by vanadium(V) dipicolinates.
Bergeron A, Kostenkova K, Selman M, Murakami HA, Owens E, Haribabu N, Arulanandam R, Diallo JS, Crans DC. Bergeron A, et al. Among authors: arulanandam r. Biometals. 2019 Jun;32(3):545-561. doi: 10.1007/s10534-019-00200-9. Epub 2019 Jun 17. Biometals. 2019. PMID: 31209680
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.
Taha Z, Arulanandam R, Maznyi G, Godbout E, Carter-Timofte ME, Kurmasheva N, Reinert LS, Chen A, Crupi MJF, Boulton S, Laroche G, Phan A, Rezaei R, Alluqmani N, Jirovec A, Acal A, Fekete EEF, Singaravelu R, Petryk J, Idorn M, Potts KG, Todesco H, John C, Mahoney DJ, Ilkow CS, Giguère P, Alain T, Côté M, Paludan SR, Olagnier D, Bell JC, Azad T, Diallo JS. Taha Z, et al. Among authors: arulanandam r. Mol Ther. 2022 Sep 7;30(9):2998-3016. doi: 10.1016/j.ymthe.2022.04.025. Epub 2022 May 6. Mol Ther. 2022. PMID: 35526097 Free PMC article.
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
Brown EEF, Rezaei R, Jamieson TR, Dave J, Martin NT, Singaravelu R, Crupi MJF, Boulton S, Tucker S, Duong J, Poutou J, Pelin A, Yasavoli-Sharahi H, Taha Z, Arulanandam R, Surendran A, Ghahremani M, Austin B, Matar C, Diallo JS, Bell JC, Ilkow CS, Azad T. Brown EEF, et al. Among authors: arulanandam r. Int J Mol Sci. 2021 Feb 25;22(5):2268. doi: 10.3390/ijms22052268. Int J Mol Sci. 2021. PMID: 33668756 Free PMC article.
48 results